InvestorsHub Logo
Followers 11
Posts 878
Boards Moderated 0
Alias Born 10/27/2003

Re: DewDiligence post# 16620

Saturday, 02/11/2017 2:58:09 PM

Saturday, February 11, 2017 2:58:09 PM

Post# of 20689
Thanks Dew for the clarity on the subject. It is my contention that each application would/wouldn't be approved by the FDA their own merits and have nothing to do with each other and/OR any being "held up" until all applications have been completely reviewed. In this case, MNTA clearly has the advantage since their 20 mg dose product has been on the market. In your opinion, am I out of touch with reality?